Former HHS official calls for FDA to control Rx drug costs

Share this article:
Former Department of Health and Human Services assistant secretary Eve Slater said the FDA should expand its current role to include the control of prescription drug costs.
Slater made the comments in an editorial she wrote appearing in the Jan. 20 edition of the New England Journal of Medicine (NEJM)
The FDA's "expertise must be brought to bear in the control of surging drug costs," she wrote.
Slater commented that the FDA "must evolve beyond satisfying the appetite of industry for faster approval of drugs."
Slater was HHS assistant secretary for health between 2002 and 2003 after working for 19 years at Merck.
Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.